izpis_h1_title_alt

APS8, a polymeric alkylpyridinium salt blocks α7 nAChR and induces apoptosis in non-small cell lung carcinoma
ID Zovko, Ana (Author), ID Viktorsson, Kristina (Author), ID Lewensohn, Rolf (Author), ID Kološa, Katja (Author), ID Filipič, Metka (Author), ID Xing, Hong (Author), ID Kem, William R. (Author), ID Paleari, Laura (Author), ID Turk, Tom (Author)

.pdfPDF - Presentation file, Download (973,50 KB)
MD5: BDA5886BD632094667F8AEEAC79ABF2F
PID: 20.500.12556/rul/518a9e8d-9b60-4d8d-a3ee-4b533aa5ee76
URLURL - Source URL, Visit http://www.mdpi.com/1660-3397/11/7/2574 This link opens in a new window

Abstract
Naturally occurring 3-alkylpyridinium polymers (poly-APS) from the marine sponge Reniera sarai, consisting of monomers containing polar pyridinium and nonpolar alkyl chain moieties, have been demonstrated to exert a wide range of biological activities, including a selective cytotoxicity against non-small cell lung cancer (NSCLC) cells. APS8, an analog of poly-APS with defined alkyl chain length and molecular size, non-competitively inhibits α7 nicotinic acetylcholine receptors (nAChRs) at nanomolar concentrations that are too low to be acetylcholinesterase (AChE) inhibitory or generally cytotoxic. In the present study we show that APS8 inhibits NSCLC tumor cell growth and activates apoptotic pathways. APS8 was not toxic for normal lung fibroblasts. Furthermore, in NSCLC cells, APS8 reduced the adverse anti-apoptotic, proliferative effects of nicotine. Our results suggest that APS8 or similar compounds might be considered as lead compounds to develop antitumor therapeutic agents for at least certain types of lung cancer.

Language:English
Keywords:3-alkylpyridinium polymers, apoptosis, nicotine, nicotinic acetylcholine receptor, non-small cell lung carcinoma
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2013
Number of pages:Str. 2574-2594
Numbering:Vol. 11, iss. 7
PID:20.500.12556/RUL-37728 This link opens in a new window
UDC:577.1
ISSN on article:1660-3397
DOI:10.3390/md11072574 This link opens in a new window
COBISS.SI-ID:2854223 This link opens in a new window
Publication date in RUL:10.07.2015
Views:1802
Downloads:491
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Marine drugs
Shortened title:Mar. drugs
Publisher:MDPI
ISSN:1660-3397
COBISS.SI-ID:23578841 This link opens in a new window

Licences

License:CC BY 3.0, Creative Commons Attribution 3.0 Unported
Link:https://creativecommons.org/licenses/by/3.0/deed.en
Description:You are free to reproduce and redistribute the material in any medium or format. You are free to remix, transform, and build upon the material for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Licensing start date:16.07.2013

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J1-4044
Name:Apoptotično delovanje alkilpiridinijevih spojin na celice pljučnega adenokarcinoma

Funder:Other - Other funder or multiple funders
Funding programme:Swedish Cancer Society
Project number:120761

Funder:Other - Other funder or multiple funders
Funding programme:Stockholm Cancer Society
Project number:10 1493

Funder:Other - Other funder or multiple funders
Funding programme:Stockholm Cancer Society
Project number:11 1213

Funder:Other - Other funder or multiple funders
Funding programme:Swedish Research Foundation
Project number:90266701/2009

Funder:Other - Other funder or multiple funders
Funding programme:Swedish National Board of Health and Welfare

Funder:Other - Other funder or multiple funders
Funding programme:Stockholm County Council

Funder:Other - Other funder or multiple funders
Funding programme:Karolinska Institutet Research Fund

Funder:EC - European Commission
Funding programme:FP7
Project number:266033
Name:Sponge Enzymes and Cells for Innovative AppLications
Acronym:SPECIAL

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back